MARKET

AMPH

AMPH

Amphastar Pharma
NASDAQ
46.02
+0.11
+0.24%
Opening 14:07 06/08 EDT
OPEN
45.97
PREV CLOSE
45.91
HIGH
46.60
LOW
45.71
VOLUME
144.41K
TURNOVER
4.52M
52 WEEK HIGH
46.86
52 WEEK LOW
26.76
MARKET CAP
2.22B
P/E (TTM)
25.81
1D
5D
1M
3M
1Y
5Y
Validea Motley Fool Strategy Daily Upgrade Report - 6/8/2023
NASDAQ · 13h ago
Amphastar Pharma: Statement of changes in beneficial ownership of securities
Press release · 18h ago
Amphastar Pharma: Current report
Press release · 2d ago
Insider Sell: Amphastar Pharmaceuticals
Insider Sell: Amphastar Pharmaceuticals
MT Newswires · 3d ago
Zacks.com featured highlights include Tecnoglass, Amphastar Pharmaceuticals, Turkcell Iletisim Hizmetleri, and Copa Holdings
NASDAQ · 3d ago
4 Solid Profitable Stocks to Invest in Using Net Income Ratio
NASDAQ · 6d ago
Tenet Healthcare (THC) Gains 42.1% YTD: More Room to Run?
NASDAQ · 05/26 12:38
Factors That Make Ensign Group (ENSG) a Lucrative Bet Now
NASDAQ · 05/25 18:07
More
About AMPH
Amphastar Pharmaceuticals, Inc. is a bio-pharmaceutical company. It is focused on developing, manufacturing, marketing and selling generic and injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (API) products. It operates through two segments: finished pharmaceutical products and API products. The finished pharmaceutical products segment manufactures, markets and distributes Primatene MIST, epinephrine, glucagon, phytonadione, lidocaine, enoxaparin, naloxone, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes RHI API and porcine insulin API for external customers and internal product development. The Company’s Primatene Mist is an epinephrine inhalation product, which is indicated for the temporary relief of mild symptoms of intermittent asthma. The Company sells two versions of naloxone injections indicated for the emergency treatment of known or suspected opioid overdose.

Webull offers kinds of Amphastar Pharmaceuticals Inc stock information, including NASDAQ:AMPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMPH stock methods without spending real money on the virtual paper trading platform.